Search
for
Sort by
Research 241–270 of 1000+
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Antibody Drug Conjugates
- How does the hair-loss drug finasteride work? Can it affect my mental health?
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Treatment options for alopecia: an update, looking to the future
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Endocrine disorders and hormonal therapy for adolescent acne
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Why Do Promising Therapies Stall in Development and How Can We Move Them Forward?
- Present Chemotherapy Induced Alopecia and Research in Future
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Novel agents for the treatment of alopecia
- Androgenetic Alopecia in Adolescents
- Physiology and Medical Treatments for Alopecia
- Innovations in skin microphysiological systems for nonclinical testing and FDA modernization
- Protocolo terapéutico de la alopecia
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- ‘Ritlecitinib: unveiling hair regrowth for alopecia areata’
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Topical minoxidil: review of efficacy and safety.
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Exploring novel management options for alopecia areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- High-throughput screening of small molecule Wnt/β-catenin activators for hair and nail growth